I imagine that BLA submission is far down list of immediate priorities at the moment. I am thinking with covid trials, ramping up manufacturing, media requests and just general administration there is not much more the 6 person team can do at the moment. Most of us longs have already made 600-1000% profit pretty much due to the potential use and exposure of Leronlimab for covid.